OncoSec Partners with Roswell Park Comprehensive Cancer Center Using CuttingEdge Intravital Microscopy TAVOPLUS and APOLLO Electroporation Generator

OncoSec Partners with Roswell Park Comprehensive Cancer Center Using Cutting-Edge Intravital Microscopy, TAVO-PLUS and APOLLO Electroporation Generator

13:42 EDT 17 Jun 2019 | Speciality Pharma Journal

SAN DIEGO, and PENNINGTON, N.J., June 17, 2019 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has initiated a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park’s intravital microscopy (IVM) and OncoSec’s proprietary plasmid, TAVOPLUS, in combination with …

More From BioPortfolio on "OncoSec Partners with Roswell Park Comprehensive Cancer Center Using Cutting-Edge Intravital Microscopy, TAVO-PLUS and APOLLO Electroporation Generator"